Rubius Therapeutics, Inc. - Common Stock (NY:ONLN)
Price and Volume
Detailed Quote| Volume | 434 |
| Open | 55.83 |
| Bid (Size) | 55.63 (5,400) |
| Ask (Size) | 56.63 (5,300) |
| Prev. Close | 55.51 |
| Today's Range | 55.83 - 55.83 |
| 52wk Range | 50.87 - 63.94 |
| Shares Outstanding | 14,500 |
| Dividend Yield | 0.17% |
Top News
More News
Performance
More News
Read More
Amazon To Cut 16,000 Jobs In Latest Bid To Cut Bureaucratic Flab ↗
January 28, 2026
Go on a Shopping Spree With 3 Top Retail ETFs ↗
December 01, 2025
A Hidden Shopping Rush Is Quietly Powering These ETFs ↗
September 02, 2025
What's Going On With Buckle Stock On Friday? ↗
May 23, 2025
Why Is eBay Stock Trading Higher On Wednesday? ↗
April 16, 2025
Frequently Asked Questions
Is Rubius Therapeutics, Inc. - Common Stock publicly traded?
Yes, Rubius Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Rubius Therapeutics, Inc. - Common Stock trade on?
Rubius Therapeutics, Inc. - Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Rubius Therapeutics, Inc. - Common Stock?
The ticker symbol for Rubius Therapeutics, Inc. - Common Stock is ONLN on the New York Stock Exchange
What is the current price of Rubius Therapeutics, Inc. - Common Stock?
The current price of Rubius Therapeutics, Inc. - Common Stock is 55.83
When was Rubius Therapeutics, Inc. - Common Stock last traded?
The last trade of Rubius Therapeutics, Inc. - Common Stock was at 09/18/26 08:00 PM ET
What is the market capitalization of Rubius Therapeutics, Inc. - Common Stock?
The market capitalization of Rubius Therapeutics, Inc. - Common Stock is 809.48K
How many shares of Rubius Therapeutics, Inc. - Common Stock are outstanding?
Rubius Therapeutics, Inc. - Common Stock has 809K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.